Uppsala University, Department of Organism Biology, 756 32 Uppsala, Sweden; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
Uppsala University, Department of Organism Biology, 756 32 Uppsala, Sweden; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
Neuropharmacology. 2024 Sep 15;256:110003. doi: 10.1016/j.neuropharm.2024.110003. Epub 2024 May 22.
Neuromodulation such as deep brain stimulation (DBS) is advancing as a clinical intervention in several neurological and neuropsychiatric disorders, including Parkinson's disease, dystonia, tremor, and obsessive-compulsive disorder (OCD) for which DBS is already applied to alleviate severely afflicted individuals of symptoms. Tourette syndrome and drug addiction are two additional disorders for which DBS is in trial or proposed as treatment. However, some major remaining obstacles prevent this intervention from reaching its full therapeutic potential. Side-effects have been reported, and not all DBS-treated individuals are relieved of their symptoms. One major target area for DBS electrodes is the subthalamic nucleus (STN) which plays important roles in motor, affective and associative functions, with impact on for example movement, motivation, impulsivity, compulsivity, as well as both reward and aversion. The multifunctionality of the STN is complex. Decoding the anatomical-functional organization of the STN could enhance strategic targeting in human patients. The STN is located in close proximity to zona incerta (ZI) and the para-subthalamic nucleus (pSTN). Together, the STN, pSTN and ZI form a highly heterogeneous and clinically important brain area. Rodent-based experimental studies, including opto- and chemogenetics as well as viral-genetic tract tracings, provide unique insight into complex neuronal circuitries and their impact on behavior with high spatial and temporal precision. This research field has advanced tremendously over the past few years. Here, we provide an inclusive review of current literature in the pre-clinical research fields centered around STN, pSTN and ZI in laboratory mice and rats; the three highly heterogeneous and enigmatic structures brought together in the context of relevance for treatment strategies. Specific emphasis is placed on methods of manipulation and behavioral impact.
神经调节,如深部脑刺激(DBS),作为一种临床干预手段,正在几种神经和神经精神疾病中得到发展,包括帕金森病、肌张力障碍、震颤和强迫症(OCD),DBS 已经用于减轻严重受影响的个体的症状。抽动秽语综合征和药物成瘾是另外两种正在进行临床试验或被提议作为治疗方法的疾病。然而,一些主要的剩余障碍阻止了这种干预达到其全部治疗潜力。已经报道了副作用,并且并非所有接受 DBS 治疗的个体都能缓解其症状。DBS 电极的一个主要目标区域是丘脑底核(STN),它在运动、情感和联想功能中发挥重要作用,对运动、动机、冲动、强迫、以及奖励和厌恶都有影响。STN 的多功能性很复杂。解码 STN 的解剖-功能组织可以增强人类患者的战略靶向。STN 位于靠近中间神经核(ZI)和旁丘脑底核(pSTN)的位置。STN、pSTN 和 ZI 一起形成了一个高度异质且具有临床重要性的脑区。基于啮齿动物的实验研究,包括光遗传学和化学遗传学以及病毒遗传轨迹追踪,提供了对复杂神经元回路及其对行为影响的独特见解,具有高空间和时间精度。这个研究领域在过去几年中取得了巨大进展。在这里,我们对实验室小鼠和大鼠中围绕 STN、pSTN 和 ZI 的临床前研究领域的当前文献进行了全面综述;这三个高度异质且神秘的结构在与治疗策略相关的背景下汇集在一起。特别强调了操纵方法和行为影响。